Lv11
60 积分 2024-12-04 加入
Large-scale screening for somatic mutations in lung cancer
6小时前
待确认
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
1个月前
已完结
Randomized phase 3 study of first-line AZD3759 (zorifertinib) versus gefitinib or erlotinib in EGFR-mutant (EGFRm+) non–small-cell lung cancer (NSCLC) with central nervous system (CNS) metastasis
2个月前
已完结
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
2个月前
已完结
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
3个月前
已完结
皖公网安备34019202002308
